SI2767285T1 - Tableta, ki vsebuje 7-(4-(4-benzo(b)tiofen-4-IL-piperazin-1-IL)butoksi)-1H-kinolin-2-ON ali njegovo sol - Google Patents

Tableta, ki vsebuje 7-(4-(4-benzo(b)tiofen-4-IL-piperazin-1-IL)butoksi)-1H-kinolin-2-ON ali njegovo sol

Info

Publication number: SI2767285T1
Authority: SI; Slovenia
Prior art keywords: quinolin; thiophen; piperazin; benzo; butoxy
Prior art date: 2011-10-14

Application number

SI201231718T

Other languages

English (en)

Other versions

SI2767285T2 (sl

Inventor

Yoshiharu Inoue

Original Assignee

Otsuka Pharmaceutical Co., Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-10-14

Filing date

2012-10-12

Publication date

2020-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48081918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2767285(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-10-12 Application filed by Otsuka Pharmaceutical Co., Ltd. filed Critical Otsuka Pharmaceutical Co., Ltd.

2020-03-31 Publication of SI2767285T1 publication Critical patent/SI2767285T1/sl

2025-06-30 Publication of SI2767285T2 publication Critical patent/SI2767285T2/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Supply Of Fluid Materials To The Packaging Location (AREA)
Basic Packing Technique (AREA)

SI201231718T 2011-10-14 2012-10-12 Tableta, ki vsebuje 7-(4-(4-benzo(b)tiofen-4-IL-piperazin-1-IL)butoksi)-1H-kinolin-2-ON ali njegovo sol SI2767285T2 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2011227057		2011-10-14
EP12840025.6A EP2767285B2 (en)	2011-10-14	2012-10-12	TABLET COMPRISING 7-[4-(4-BENZO[b]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF
PCT/JP2012/076415 WO2013054872A1 (ja)	2011-10-14	2012-10-12	７－［４－（４－ベンゾ［ｂ］チオフェン－４－イル－ピペラジン－１－イル）ブトキシ］－１Ｈ－キノリン－２－オン又はその塩を含む錠剤

Publications (2)

Publication Number	Publication Date
SI2767285T1 true SI2767285T1 (sl)	2020-03-31
SI2767285T2 SI2767285T2 (sl)	2025-06-30

Family

ID=48081918

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201231718T SI2767285T2 (sl)	2011-10-14	2012-10-12	Tableta, ki vsebuje 7-(4-(4-benzo(b)tiofen-4-IL-piperazin-1-IL)butoksi)-1H-kinolin-2-ON ali njegovo sol

Country Status (34)

Country	Link
US (8)	US20140234417A1 (sl)
EP (1)	EP2767285B2 (sl)
JP (2)	JP6084161B2 (sl)
KR (1)	KR102072371B1 (sl)
CN (2)	CN107397730A (sl)
AP (1)	AP2014007564A0 (sl)
AR (1)	AR088319A1 (sl)
AU (1)	AU2012321723C1 (sl)
BR (1)	BR112014008603A2 (sl)
CA (1)	CA2851588C (sl)
CL (1)	CL2014000909A1 (sl)
CO (1)	CO6950480A2 (sl)
CY (1)	CY1122460T1 (sl)
DK (1)	DK2767285T4 (sl)
EA (1)	EA032930B1 (sl)
ES (1)	ES2762479T5 (sl)
FI (1)	FI2767285T4 (sl)
HR (1)	HRP20200037T4 (sl)
HU (1)	HUE047493T2 (sl)
IL (1)	IL231513B (sl)
IN (1)	IN2014DN02055A (sl)
JO (1)	JO3753B1 (sl)
LT (1)	LT2767285T (sl)
MX (1)	MX376092B (sl)
MY (1)	MY173370A (sl)
PH (1)	PH12014500607A1 (sl)
PL (1)	PL2767285T5 (sl)
PT (1)	PT2767285T (sl)
SG (2)	SG2014013783A (sl)
SI (1)	SI2767285T2 (sl)
TW (1)	TWI634908B (sl)
UA (1)	UA114411C2 (sl)
WO (1)	WO2013054872A1 (sl)
ZA (1)	ZA201402333B (sl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI320783B (en)	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
JO3753B1 (ar) *	2011-10-14	2021-01-31	Otsuka Pharma Co Ltd	قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
JOP20200109A1 (ar)	2012-04-23	2017-06-16	Otsuka Pharma Co Ltd	مستحضر قابل للحقن
JP5936732B1 (ja) *	2015-03-05	2016-06-22	日本カラコン合同会社	フィルムコーティング組成物
CN105106142B (zh) *	2015-09-22	2018-05-22	成都欣捷高新技术开发有限公司	一种含有依匹哌唑的冻干口服制剂及其制备方法
CN106994119A (zh) *	2016-01-22	2017-08-01	浙江华海药业股份有限公司	含有依匹哌唑或其盐的口腔崩解片及其制备方法
US10786507B2 (en) *	2016-02-19	2020-09-29	Jiangsu Hengrui Medicine Co., Ltd.	Pharmaceutical composition containing JAK kinase inhibitor or pharmaceutically acceptable salt thereof
KR20190022709A (ko) *	2016-06-28	2019-03-06	가부시키가이샤 니폰 고킨 소고 겐큐쇼	부형제 및 정제
JP7060878B2 (ja) *	2016-07-27	2022-04-27	日本臓器製薬株式会社	メトトレキサート含有フィルムコーティング錠
WO2018033484A1 (en)	2016-08-16	2018-02-22	Hexal Aktiengesellschaft	Pharmaceutical compositions of a benzothiophene compound
EP3500247B1 (en)	2016-08-16	2020-05-27	H e x a l Aktiengesellschaft	Immediate release tablet of a benzothiophene compound
CN106496206A (zh) *	2016-08-31	2017-03-15	安徽省润生医药股份有限公司	一种依匹哌唑新的制备方法
MX391810B (es) *	2017-02-23	2025-03-21	Boehringer Ingelheim Int	Nuevo uso medico del compuesto iii.
JP7166754B2 (ja) *	2017-11-22	2022-11-08	沢井製薬株式会社	ダサチニブ無水物含有製剤
EP3501506B1 (en)	2017-12-19	2019-10-09	Alfred E. Tiefenbacher (GmbH & Co. KG)	Pharmaceutical tablet composition comprising brexpiprazole
EP3545950A1 (en) *	2018-03-26	2019-10-02	Adamed sp. z o.o.	Pharmaceutical composition comprising brexpiprazole
WO2021029020A1 (ja) *	2019-08-13	2021-02-18	大塚製薬株式会社	経口医薬組成物
WO2021095092A1 (ja) *	2019-11-11	2021-05-20	大塚製薬株式会社	口腔内崩壊錠
CN112168794A (zh) *	2020-10-27	2021-01-05	浙江诺得药业有限公司	一种布瑞哌唑片的制备方法
WO2022218358A1 (zh) *	2021-04-13	2022-10-20	上海博志研新药物技术有限公司	一种布瑞哌唑物口腔薄膜剂、其制备方法及应用
EP4374856A1 (en)	2022-11-23	2024-05-29	Sanovel Ilac Sanayi Ve Ticaret A.S.	A process for tablets comprising brexpiprazole

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6562375B1 (en) *	1999-08-04	2003-05-13	Yamanouchi Pharmaceuticals, Co., Ltd.	Stable pharmaceutical composition for oral use
WO2003055467A1 (en) *	2001-12-18	2003-07-10	Synthon B.V.	Simvastatin dosage forms
KR101027570B1 (ko) *	2002-05-03	2011-04-06	이스라엘 인스티튜트 포 바이올로지컬 리서치	중추 및 말초 신경계 장애의 치료를 위한 방법 및 조성물, 및 그에 유용한 신규 화합물
DK1620437T3 (da)	2003-04-29	2009-08-24	Pfizer Ltd	5,7-diaminopyrazolo-4,3-d-pyrimidiner, der er anvendelige til behandling af hypertension
EP1648944A1 (en) *	2003-06-09	2006-04-26	The Dow Global Technologies Inc.	Stabilized organoborane polymerization initiators and polymerizable compositions
JP2006061067A (ja) *	2004-08-26	2006-03-09	Asahi Kasei Life & Living Corp	酸素インジケーター
GB0504203D0 (en) *	2005-03-01	2005-04-06	Novartis Ag	Organic compounds
EP1858514B1 (en)	2005-03-17	2014-11-26	Synthon B.V.	Pharmaceutical tablets of crystalline type ii aripiprazole
TWI320783B (en) *	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
JP4315393B2 (ja) *	2005-04-14	2009-08-19	大塚製薬株式会社	複素環化合物
EP1808164B2 (en)	2006-01-05	2018-07-04	Teva Pharmaceutical Industries Ltd	Wet granulation method for preparing pharmaceutical compositions of aripiprazole
JP4806595B2 (ja) *	2006-07-05	2011-11-02	富士フイルム株式会社	固体撮像素子駆動装置及びデジタルカメラ
JP4540700B2 (ja) *	2006-10-13	2010-09-08	大塚製薬株式会社	医薬
WO2008106059A1 (en) *	2007-02-26	2008-09-04	Merck & Co., Inc.	Formulations for cathepsin k inhibitors
US7994183B2 (en) *	2007-03-13	2011-08-09	Takeda Pharmaceutical Company Limited	Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile
CA2686394A1 (en) *	2007-05-11	2008-11-20	Santen Pharmaceutical Co., Ltd.	Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
MX2010003989A (es)	2007-10-12	2010-04-27	Astrazeneca Ab	Composicion zibotentan que contiene mannitol y/o celulosa microcristalina.
JP5463564B2 (ja) *	2009-05-22	2014-04-09	国立大学法人信州大学	耐熱性及び耐塩性セルラーゼ製剤
TR201000948A1 (tr)	2010-02-09	2011-08-22	Sanovel İlaç San.Ve Ti̇c.A.Ş.	Aripiprazol formülasyonları.
JOP20120083B1 (ar) *	2011-04-05	2021-08-17	Otsuka Pharma Co Ltd	توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns
ES2606511T3 (es)	2011-04-06	2017-03-24	Biovaxim Limited	Composiciones farmacéuticas para prevenir y/o tratar una enfermedad por VIH en seres humanos
JO3753B1 (ar) *	2011-10-14	2021-01-31	Otsuka Pharma Co Ltd	قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه

2012
- 2012-10-04 JO JOP/2012/0301A patent/JO3753B1/ar active
- 2012-10-09 TW TW101137267A patent/TWI634908B/zh active
- 2012-10-12 AU AU2012321723A patent/AU2012321723C1/en active Active
- 2012-10-12 DK DK12840025.6T patent/DK2767285T4/da active
- 2012-10-12 FI FIEP12840025.6T patent/FI2767285T4/fi active
- 2012-10-12 PH PH1/2014/500607A patent/PH12014500607A1/en unknown
- 2012-10-12 EA EA201490783A patent/EA032930B1/ru active Protection Beyond IP Right Term
- 2012-10-12 LT LTEP12840025.6T patent/LT2767285T/lt unknown
- 2012-10-12 BR BR112014008603A patent/BR112014008603A2/pt not_active Application Discontinuation
- 2012-10-12 CN CN201710266863.7A patent/CN107397730A/zh active Pending
- 2012-10-12 CA CA2851588A patent/CA2851588C/en active Active
- 2012-10-12 HU HUE12840025A patent/HUE047493T2/hu unknown
- 2012-10-12 SG SG2014013783A patent/SG2014013783A/en unknown
- 2012-10-12 AR ARP120103801A patent/AR088319A1/es not_active Application Discontinuation
- 2012-10-12 CN CN201280050586.1A patent/CN103889425B/zh active Active
- 2012-10-12 HR HRP20200037TT patent/HRP20200037T4/hr unknown
- 2012-10-12 MY MYPI2014700632A patent/MY173370A/en unknown
- 2012-10-12 UA UAA201405029A patent/UA114411C2/uk unknown
- 2012-10-12 US US14/351,325 patent/US20140234417A1/en not_active Abandoned
- 2012-10-12 PT PT128400256T patent/PT2767285T/pt unknown
- 2012-10-12 PL PL12840025.6T patent/PL2767285T5/pl unknown
- 2012-10-12 AP AP2014007564A patent/AP2014007564A0/xx unknown
- 2012-10-12 MX MX2014004135A patent/MX376092B/es active IP Right Grant
- 2012-10-12 SG SG10201608412SA patent/SG10201608412SA/en unknown
- 2012-10-12 JP JP2013538582A patent/JP6084161B2/ja active Active
- 2012-10-12 WO PCT/JP2012/076415 patent/WO2013054872A1/ja not_active Ceased
- 2012-10-12 SI SI201231718T patent/SI2767285T2/sl unknown
- 2012-10-12 EP EP12840025.6A patent/EP2767285B2/en active Active
- 2012-10-12 KR KR1020147010656A patent/KR102072371B1/ko active Active
- 2012-10-12 ES ES12840025T patent/ES2762479T5/es active Active
2014
- 2014-03-13 IL IL231513A patent/IL231513B/en active IP Right Grant
- 2014-03-19 IN IN2055DEN2014 patent/IN2014DN02055A/en unknown
- 2014-03-28 ZA ZA2014/02333A patent/ZA201402333B/en unknown
- 2014-04-10 CL CL2014000909A patent/CL2014000909A1/es unknown
- 2014-05-07 CO CO14098041A patent/CO6950480A2/es unknown
2016
- 2016-02-09 US US15/019,874 patent/US20160158227A1/en not_active Abandoned
2017
- 2017-01-20 JP JP2017008854A patent/JP2017088610A/ja active Pending
- 2017-02-27 US US15/444,113 patent/US20170165258A1/en not_active Abandoned
- 2017-09-22 US US15/713,427 patent/US10307419B2/en active Active
2019
- 2019-04-12 US US16/383,488 patent/US20190240215A1/en not_active Abandoned
2020
- 2020-01-08 CY CY20201100009T patent/CY1122460T1/el unknown
- 2020-10-01 US US17/061,394 patent/US20210023078A1/en not_active Abandoned
2022
- 2022-03-07 US US17/653,838 patent/US20220331311A1/en not_active Abandoned
2023
- 2023-12-18 US US18/543,053 patent/US20240277703A1/en active Pending

Also Published As

Publication number	Publication date
EP2767285B2 (en)	2025-02-19
US20190240215A1 (en)	2019-08-08
UA114411C2 (uk)	2017-06-12
CY1122460T1 (el)	2021-01-27
JP2017088610A (ja)	2017-05-25
EA201490783A1 (ru)	2014-07-30
LT2767285T (lt)	2020-02-10
CA2851588A1 (en)	2013-04-18
US20210023078A1 (en)	2021-01-28
KR20140075754A (ko)	2014-06-19
HUE047493T2 (hu)	2020-04-28
ES2762479T5 (en)	2025-05-30
AP2014007564A0 (en)	2014-04-30
CN103889425A (zh)	2014-06-25
CN107397730A (zh)	2017-11-28
IN2014DN02055A (sl)	2015-05-15
PL2767285T3 (pl)	2020-04-30
IL231513B (en)	2020-01-30
MX2014004135A (es)	2014-07-24
CA2851588C (en)	2019-07-02
BR112014008603A2 (pt)	2017-04-18
FI2767285T4 (fi)	2025-05-08
AR088319A1 (es)	2014-05-28
ES2762479T3 (es)	2020-05-25
HRP20200037T1 (hr)	2020-03-20
PL2767285T5 (pl)	2025-06-02
ZA201402333B (en)	2015-07-29
MY173370A (en)	2020-01-21
SG10201608412SA (en)	2016-12-29
EP2767285A1 (en)	2014-08-20
US20140234417A1 (en)	2014-08-21
EP2767285B1 (en)	2019-11-27
TW201318651A (zh)	2013-05-16
DK2767285T4 (da)	2025-04-22
EP2767285A4 (en)	2015-03-11
US20160158227A1 (en)	2016-06-09
IL231513A0 (en)	2014-04-30
JP6084161B2 (ja)	2017-02-22
HRP20200037T4 (hr)	2025-05-23
KR102072371B1 (ko)	2020-02-03
PT2767285T (pt)	2020-01-21
US20240277703A1 (en)	2024-08-22
DK2767285T3 (da)	2020-01-27
SI2767285T2 (sl)	2025-06-30
US20180008600A1 (en)	2018-01-11
CL2014000909A1 (es)	2014-11-21
CO6950480A2 (es)	2014-05-20
AU2012321723C1 (en)	2017-11-02
JO3753B1 (ar)	2021-01-31
EA032930B1 (ru)	2019-08-30
PH12014500607A1 (en)	2014-04-21
TWI634908B (zh)	2018-09-11
AU2012321723A1 (en)	2014-05-15
SG2014013783A (en)	2014-06-27
US20170165258A1 (en)	2017-06-15
US20220331311A1 (en)	2022-10-20
NZ622639A (en)	2015-11-27
AU2012321723B2 (en)	2017-07-20
JPWO2013054872A1 (ja)	2015-03-30
WO2013054872A1 (ja)	2013-04-18
MX376092B (es)	2025-03-07
US10307419B2 (en)	2019-06-04
CN103889425B (zh)	2018-08-03

Publication	Publication Date	Title
SI2767285T2 (sl)	2025-06-30	Tableta, ki vsebuje 7-(4-(4-benzo(b)tiofen-4-IL-piperazin-1-IL)butoksi)-1H-kinolin-2-ON ali njegovo sol
EP2695134A4 (en)	2014-09-17	EVENT REGARDING PHOTOS
GB201115410D0 (en)	2011-10-19	Asset condition monitoring
GB201512393D0 (en)	2015-08-19	Vest
GB201220441D0 (en)	2012-12-26	Password-free token-based wireless access
GB201113478D0 (en)	2011-09-21	Sensing systems
IL229087B (en)	2019-05-30	Wireless sensor reader
GB201208414D0 (en)	2012-06-27	Processing state information
GB2494890B (en)	2015-09-30	Inventorying transponders
EP2653006A4 (en)	2017-08-09	Wireless sensor network information swarming
PT2575503E (pt)	2014-07-25	Produto compreendendo catequinas
GB201108356D0 (en)	2011-06-29	Event identification
EP2762479A4 (en)	2015-04-22	OXAZOLIDINONE ANTIBACTERIAL MEDICINE BASED ON BIARYLIC HETEROCYCLE SUBSTITUTED
SG10201602390WA (en)	2016-04-28	Personal Identification Number At Account Level
HUE047982T2 (hu)	2020-05-28	Szinterelt üvegtermék
GB201009279D0 (en)	2010-07-21	An outer garment for privacy when breastfeeding
GB2491042B (en)	2018-03-21	Supervised data transfer
GB201112179D0 (en)	2011-08-31	Drop alarm
GB201108458D0 (en)	2011-07-06	Card protector
AU338175S (en)	2011-08-19	Cardigan
AU337630S (en)	2011-07-13	Cardigan
AU338686S (en)	2011-09-28	Cardigan
GB201105845D0 (en)	2011-05-18	New pocket
AU345801S (en)	2012-11-29	Fishing reel pocket
PH32011000847S1 (en)	2012-10-08	Pill case